Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.

Stewart CJ, Alexiadis M, Crook ML, Fuller PJ.

Hum Pathol. 2013 Dec;44(12):2774-81. doi: 10.1016/j.humpath.2013.07.028. Epub 2013 Oct 14.

PMID:
24134930
2.

FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.

Al-Agha OM, Huwait HF, Chow C, Yang W, Senz J, Kalloger SE, Huntsman DG, Young RH, Gilks CB.

Am J Surg Pathol. 2011 Apr;35(4):484-94. doi: 10.1097/PAS.0b013e31820a406c.

PMID:
21378549
3.

Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.

Zhao C, Vinh TN, McManus K, Dabbs D, Barner R, Vang R.

Am J Surg Pathol. 2009 Mar;33(3):354-66. doi: 10.1097/PAS.0b013e318188373d.

PMID:
19033865
4.

Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.

Oost EE, Charles A, Choong CS, Leung YC, Salfinger S, Sonnendecker H, Tan J, Townshend S, Witkowski L, Foulkes WD, Stewart CJ.

Int J Gynecol Pathol. 2015 May;34(3):266-74. doi: 10.1097/PGP.0000000000000150.

PMID:
25844550
5.

CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.

McCluggage WG, McKenna M, McBride HA.

Int J Gynecol Pathol. 2007 Jul;26(3):322-7.

PMID:
17581419
6.
7.

CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.

Oliva E, Garcia-Miralles N, Vu Q, Young RH.

Int J Gynecol Pathol. 2007 Oct;26(4):359-67.

PMID:
17885484
8.

Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin.

Deavers MT, Malpica A, Liu J, Broaddus R, Silva EG.

Mod Pathol. 2003 Jun;16(6):584-90.

10.
11.

A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.

Conlon N, Schultheis AM, Piscuoglio S, Silva A, Guerra E, Tornos C, Reuter VE, Soslow RA, Young RH, Oliva E, Weigelt B.

Mod Pathol. 2015 Dec;28(12):1603-12. doi: 10.1038/modpathol.2015.115. Epub 2015 Oct 2.

12.

FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors.

Chiang S, Staats PN, Senz J, Kommoss F, De Nictolis M, Huntsman DG, Gilks CB, Oliva E.

Am J Surg Pathol. 2015 May;39(5):618-23. doi: 10.1097/PAS.0000000000000367.

PMID:
25581731
13.

Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.

Maillet D, Goulvent T, Rimokh R, Vacher-Lavenu MC, Pautier P, Alexandre J, Pujade-Laurraine E, Devouassoux-Shisheboran M, Treilleux I, Ray-Coquard I, Savina A.

Gynecol Oncol. 2014 Jan;132(1):181-7. doi: 10.1016/j.ygyno.2013.10.013. Epub 2013 Oct 22.

PMID:
24157616
14.

Lack of mutation of DICER1 and FOXL2 genes in microcystic stromal tumor of the ovary.

Meurgey A, Descotes F, Mery-Lamarche E, Devouassoux-Shisheboran M.

Virchows Arch. 2017 Feb;470(2):225-229. doi: 10.1007/s00428-016-2038-2. Epub 2016 Nov 9.

PMID:
27830327
15.
17.

Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7.

Guerrieri C, FrÄnlund B, Malmström H, Boeryd B.

Int J Gynecol Pathol. 1998 Jul;17(3):266-71.

PMID:
9656124
18.

Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool.

Costa MJ, Ames PF, Walls J, Roth LM.

Hum Pathol. 1997 Nov;28(11):1247-54.

PMID:
9385929
20.

14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.

Chen L, Yang B.

Int J Gynecol Pathol. 2013 Mar;32(2):156-62. doi: 10.1097/PGP.0b013e31825a0353.

PMID:
23370648

Supplemental Content

Support Center